These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 15200155)
21. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis. Wong CF; McCarthy M; Howse ML; Williams PS Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158 [TBL] [Abstract][Full Text] [Related]
23. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status. Box RJ; Spielmann H Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470 [TBL] [Abstract][Full Text] [Related]
24. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling. Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223 [TBL] [Abstract][Full Text] [Related]
25. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney]. Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964 [TBL] [Abstract][Full Text] [Related]
26. Dosimetry considerations in the enhanced sensitivity of male Wistar rats to chronic ethylene glycol-induced nephrotoxicity. Corley RA; Wilson DM; Hard GC; Stebbins KE; Bartels MJ; Soelberg JJ; Dryzga MD; Gingell R; McMartin KE; Snellings WM Toxicol Appl Pharmacol; 2008 Apr; 228(2):165-78. PubMed ID: 18191429 [TBL] [Abstract][Full Text] [Related]
27. Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection. Rhomberg LR; Baetcke K; Blancato J; Bus J; Cohen S; Conolly R; Dixit R; Doe J; Ekelman K; Fenner-Crisp P; Harvey P; Hattis D; Jacobs A; Jacobson-Kram D; Lewandowski T; Liteplo R; Pelkonen O; Rice J; Somers D; Turturro A; West W; Olin S Crit Rev Toxicol; 2007; 37(9):729-837. PubMed ID: 17957539 [TBL] [Abstract][Full Text] [Related]
28. Final report on the safety assessment of Glycyrrhetinic Acid, Potassium Glycyrrhetinate, Disodium Succinoyl Glycyrrhetinate, Glyceryl Glycyrrhetinate, Glycyrrhetinyl Stearate, Stearyl Glycyrrhetinate, Glycyrrhizic Acid, Ammonium Glycyrrhizate, Dipotassium Glycyrrhizate, Disodium Glycyrrhizate, Trisodium Glycyrrhizate, Methyl Glycyrrhizate, and Potassium Glycyrrhizinate. Cosmetic Ingredient Review Expert Panel Int J Toxicol; 2007; 26 Suppl 2():79-112. PubMed ID: 17613133 [TBL] [Abstract][Full Text] [Related]
29. Adrenal toxicology: a strategy for assessment of functional toxicity to the adrenal cortex and steroidogenesis. Harvey PW; Everett DJ; Springall CJ J Appl Toxicol; 2007; 27(2):103-15. PubMed ID: 17265431 [TBL] [Abstract][Full Text] [Related]
30. Detection and evaluation of chronic kidney disease. Snyder S; Pendergraph B Am Fam Physician; 2005 Nov; 72(9):1723-32. PubMed ID: 16300034 [TBL] [Abstract][Full Text] [Related]
32. NTP carcinogenesis studies of 2,2-bis(bromomethyl)-1,3-propanediol, nitromethane, and 1,2,3-trichloropropane (cas nos. 3296-90-0, 75-52-5, and 96-18-4) in guppies (Poecilia reticulata) and medaka (Oryzias latipes) (Waterborne Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2005 Oct; (528):1-190. PubMed ID: 16362062 [TBL] [Abstract][Full Text] [Related]
33. Excess weight as a risk factor for kidney failure. Nguyen S; Hsu CY Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):71-6. PubMed ID: 17293680 [TBL] [Abstract][Full Text] [Related]
34. [Diabetic nephropathy and prevention of diabetic nephropathy caused chronic renal insufficiency]. Jakić M; Jakić M; Zibar L; Mihaljević D; Stipanić S; Teskera T Lijec Vjesn; 2009; 131(7-8):218-25. PubMed ID: 19769285 [TBL] [Abstract][Full Text] [Related]
35. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity. Müller L; Gocke E; Lavé T; Pfister T Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141 [TBL] [Abstract][Full Text] [Related]
36. Relationship between chronic kidney disease prevalence and end-stage renal disease risk. Hallan SI; Vikse BE Curr Opin Nephrol Hypertens; 2008 May; 17(3):286-91. PubMed ID: 18408480 [TBL] [Abstract][Full Text] [Related]
37. Functional and oncological outcomes of partial nephrectomy of solitary kidneys. La Rochelle J; Shuch B; Riggs S; Liang LJ; Saadat A; Kabbinavar F; Pantuck A; Belldegrun A J Urol; 2009 May; 181(5):2037-42; discussion 2043. PubMed ID: 19298974 [TBL] [Abstract][Full Text] [Related]
38. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients. Steinke JM; Mauer M; Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710 [TBL] [Abstract][Full Text] [Related]